4:15–4:30

Biomarkers for Psychiatric Drug Toxicity: Opportunities and Challenges

THOMAS INSEL

National Institute of Mental Health

4:30–5:30

Panel Discussion—Integration of New Science into Drug Safety Prediction and Assessment

 

  • How can we develop more efficient approaches to biomarker evaluation and qualification in animals and humans?

  • What potential policies could be enacted to help guide this effort?

  • How could these efforts be advanced through public or private means?

5:30

ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement